Chromatin immunoprecipitation analysis of gene expression in the rat uterus in vivo: Estrogen-induced recruitment of both estrogen receptor α and hypoxia-inducible factor 1 to the vascular endothelial growth factor promoter

Molecular Endocrinology

Volumn 19, Issue 8, 2005, Pages 2006-2019

  Kazi, Armina A ^a   Jones, Jenny M ^a   Koos, Robert D ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; HYPOXIA INDUCIBLE FACTOR 1; MESSENGER RNA; OXYGEN; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; VASCULOTROPIN;

AIR; ALPHA CHAIN; ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; BETA CHAIN; CELL CULTURE; CELL LINE; CELL TYPE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION ANALYSIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; UTERUS; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; EDEMA; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MODELS, BIOLOGICAL; MODELS, GENETIC; OXYGEN; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RATS; RNA, MESSENGER; SP1 TRANSCRIPTION FACTOR; TIME FACTORS; UTERUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 23644441755     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2004-0388     Document Type: Article

References (88)

1. Ferrara N 1999 Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77:527-543
2. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z 1999 Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13:9-22
3. Rockwell LC, Pillai S, Olson CE, Koos RD 2002 Inhibition of vascular endothelial growth factor/vascular permeability factor action blocks estrogen-induced uterine edema and implantation in rodents. Biol Reprod 67:1804-1810
4. Koos RD, Rockwell LC 2005 The microvasculature of the endometrium. In: Shepro D, ed. Microvascular research: biology and pathology. San Diego: Academic Press/Elsevier; 557-564
5. Cullinan-Bove K, Koos RD 1993 Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology 133:829-837
6. Hyder SM, Stancel GM, Chiappetta C, Murthy L, Boettger-Tong HL, Makela S 1996 Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen. Cancer Res 56:3954-3960
7. Hyder SM, Stancel GM 2000 Regulation of VEGF in the reproductive tract by sex-steroid hormones. Histol Histopathol 15:325-334
8. Mueller MD, Vigne JL, Minchenko A, Lebovic DI, Leitman DC, Taylor RN 2000 Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors α and β. Proc Natl Acad Sci USA 97:10972-10977
9. Umayahara Y, Kawamori R, Watada H, Imano E, Iwama N, Morishima T, Yamasaki Y, Kajimoto Y, Kamada T 1994 Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J Biol Chem 269:16433-16442
10. Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, Scanlan TS 1997 Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 277:1508-1510
11. Klinge CM 2001 Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 29:2905-2919
12. Stoner M, Wang F, Wormke M, Nguyen T, Samudio I, Vyhlidal C, Marme D, Finkenzeller G, Safe S 2000 Inhibition of vascular endothelial growth factor expression in HEC1A endometrial cancer cells through interactions of estrogen receptor α and Sp3 proteins. J Biol Chem 275:22769-22779
13. Stoner M, Wormke M, Saville B, Samudio I, Qin C, Abdelrahim M, Safe S 2004 Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor α and SP proteins. Oncogene 23:1052-1063
14. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL 1996 Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604-4613
15. Semenza GL 2003 Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721-732
16. Stroka DM, Burkhardt T, Desbaillets I, Wenger RH, Neil DA, Bauer C, Gassmann M, Candinas D 2001 HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J 15:2445-2453
17. Wiener CM, Booth G, Semenza GL 1996 In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem Biophys Res Commun 225:485-488
18. 2 sensing. Science 292:464-468
19. 2-regulated prolyl hydroxylation. Science 292:468-472
20. Zelzer E, Levy Y, Kahana C, Shilo BZ, Rubinstein M, Cohen B 1998 Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1α/ARNT. EMBO J 17:5085-5094
21. Richard DE, Berra E, Pouyssegur J 2000 Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1α in vascular smooth muscle cells. J Biol Chem 275:26765-26771
22. Gorlach A, Diebold I, Schini-Kerth VB, Berchner-Pfannschmidt U, Roth U, Brandes RP, Kietzmann T, Busse R 2001 Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: role of the p22(phox)-containing NADPH oxidase. Circ Res 89:47-54
23. Spinella F, Rosano L, Di Castro, V, Natali PG, Bagnato A 2002 Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1α in ovarian carcinoma cells. J Biol Chem 277:27850-27855
24. Fukuda R, Hirota K, Fan F, Jung YD, Ellis LM, Semenza GL 2002 Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 277:38205-38211
25. 2 is mediated by hypoxia-inducible factor 1. Cancer Res 63:2330-2334
26. Mabjeesh NJ, Willard MT, Frederickson CE, Zhong H, Simons JW 2003 Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3′-kinase/protein kinase B in prostate cancer cells. Clin Cancer Res 9:2416-2425
27. Qian D, Lin HY, Wang HM, Zhang X, Liu DL, Li QL, Zhu C 2004 Normoxic induction of the hypoxic-inducible factor-1α by interleukin-1α involves the extracellular signal-regulated kinase 1/2 pathway in normal human cytotrophoblast cells. Biol Reprod 70:1822-1827
28. Kasuno K, Takabuchi S, Fukuda K, Kizaka-Kondoh S, Yodoi J, Adachi T, Semenza GL, Hirota K 2004 Nitric oxide induces hypoxia-inducible factor 1 activation that is dependent on MAPK and phosphatidylinositol 3-kinase signaling. J Biol Chem 279:2550-2558
29. Gao N, Nester RA, Sarkar MA 2004 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1α and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells. Toxicol Appl Pharmacol 196:124-135
30. Kuo MH, Allis CD 1999 In vivo cross-linking and immunoprecipitation for studying dynamic protein:DNA associations in a chromatin environment. Methods 19:425-433
31. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M 2000 Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843-852
32. Wang F, Samudio I, Safe S 2001 Transcriptional activation of rat creatine kinase B by 17β-estradiol in MCF-7 cells involves an estrogen responsive element and GC-rich sites. J Cell Biochem 84:156-172
33. Oh SY, Park SK, Kim JW, Ahn YH, Park SW, Kim KS 2003 Acetyl-CoA carboxylase β gene is regulated by sterol regulatory element-binding protein-1 in liver. J Biol Chem 278:28410-28417
34. Woelfle J, Chia DJ, Rotwein P 2003 Mechanisms of growth hormone (GH) action. Identification of conserved Stat5 binding sites that mediate GH-induced insulin-like growth factor-I gene activation. J Biol Chem 278:51261-51266
35. Pentecost BT, Mattheiss L, Dickerman HW, Kumar SA 1990 Estrogen regulation of creatine kinase-B in the rat uterus. Mol Endocrinol 4:1000-1010
36. Finkenzeller G, Sparacio A, Technau A, Marme D, Siemeister G 1997 Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression. Oncogene 15:669-676
37. Gille J, Swerlick RA, Caughman SW 1997 Transforming growth factor-β-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation. EMBO J 16:750-759
38. Milanini J, Vinals F, Pouyssegur J, Pages G 1998 p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts. J Biol Chem 273:18165-18172
39. Ryuto M, Ono M, Izumi H, Yoshida S, Weich HA, Kohno K, Kuwano M 1996 Induction of vascular endothelial growth factor by tumor necrosis factor β in human glioma cells. Possible roles of SP-1. J Biol Chem 271:28220-28228
40. Salimath B, Marme D, Finkenzeller G 2000 Expression of the vascular endothelial growth factor gene is inhibited by p73. Oncogene 19:3470-3476
41. Shi Q, Le X, Wang B, Abbruzzese JL, Xiong Q, He Y, Xie K 2001 Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells. Oncogene 20:3751-3756
42. Levy AP, Levy NS, Wegner S, Goldberg MA 1995 Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 270:13333-13340
43. Arany Z, Huang LE, Eckner R, Bhattacharya S, Jiang C, Goldberg MA, Bunn HF, Livingston DM 1996 An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci USA 93:12969-12973
44. Ebert BL, Bunn HF 1998 Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor, and p300/CREB binding protein. Mol Cell Biol 18:4089-4096
45. Semenza G 2002 Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 64:993-998
46. Page EL, Robitaille GA, Pouyssegur J, Richard DE 2002 Induction of hypoxia-inducible factor-1α by transcriptional and translational mechanisms. J Biol Chem 277:48403-48409
47. Sanchez-Elsner T, Botella LM, Velasco B, Corbi A, Attisano L, Bernabeu C 2001 Synergistic cooperation between hypoxia and transforming growth factor-β pathways on human vascular endothelial growth factor gene expression. J Biol Chem 276:38527-38535
48. Berra E, Milanini J, Richard DE, Le Gall M, Vinals F, Gothie E, Roux D, Pages G, Pouyssegur J 2000 Signaling angiogenesis via p42/p44 MAP kinase and hypoxia. Biochem Pharmacol 60:1171-1178
49. Hyder SM, Murthy L, Stancel GM 1998 Progestin regulation of vascular endothelial growth factor in human breast cancer cells. Cancer Res 58:392-395
50. Bogin L, Degani H 2002 Hormonal regulation of VEGF in orthotopic MCF7 human breast cancer. Cancer Res 62:1948-1951
51. Scott PA, Gleadle JM, Bicknell R, Harris AL 1998 Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines. Int J Cancer 75:706-712
52. Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M 2002 Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors α and β. Cancer Res 62:4977-4984
53. Reisinger K, Kaufmann R, Gille J 2003 Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription. J Cell Sci 116:225-238
54. Safe S 2001 Transcriptional activation of genes by 17β-estradiol through estrogen receptor-Sp1 interactions. Vitam Horm 62:231-252
55. Khan S, Abdelrahim M, Samudio I, Safe S 2003 Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17β-estradiol in breast cancer cells. Endocrinology 144:2325-2335
56. Cameron VA, Autelitano DJ, Evans JJ, Ellmers LJ, Espiner EA, Nicholls MG, Richards AM 2002 Adrenomedullin expression in rat uterus is correlated with plasma estradiol. Am J Physiol Endocrinol Metab 282:E139-E146
57. Economos K, MacDonald PC, Casey ML 1992 Endothelin-1 gene expression and biosynthesis in human endometrial HEC1A cancer cells. Cancer Res 52:554-557
58. Yokomizo R, Matsuzaki S, Uehara S, Murakami T, Yaegashi N, Okamura K 2002 Erythropoietin and erythropoietin receptor expression in human endometrium throughout the menstrual cycle. Mol Hum Reprod 8:441-446
59. Giudice LC, Milkowski DA, Fielder PJ, Irwin JC 1991 Characterization of the steroid-dependence of insulin-like growth factor-binding protein-2 synthesis and mRNA expression in cultured human endometrial stromal cells. Hum Reprod 6:632-640
60. Cameron IT, Campbell S 1998 Nitric oxide in the endometrium. Hum Reprod Update 4:565-569
61. 2-regulated gene expression. FASEB J 16:1151-1162
62. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E, Auricchio F 1996 Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15:1292-1300
63. Endoh H, Sasaki H, Maruyama K, Takeyama K, Waga I, Shimizu T, Kato S, Kawashima H 1997 Rapid activation of MAP kinase by estrogen in the bone cell line. Biochem Biophys Res Commun 235:99-102
64. Sun M, Paciga JE, Feldman RI, Yuan Z, Coppola D, Lu YY, Shelley SA, Nicosia SV, Cheng JQ 2001 Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor α (ERα) via interaction between ERα and PI3K. Cancer Res 61:5985-5991
65. Simoncini T, Fornari L, Mannella P, Varone G, Caruso A, Liao JK, Genazzani AR 2002 Novel non-transcriptional mechanisms for estrogen receptor signaling in the cardiovascular system. Interaction of estrogen receptor α with phosphatidylinositol 3-OH kinase. Steroids 67:935-939
66. Farach-Carson MC, Davis PJ 2003 Steroid hormone interactions with target cells: cross talk between membrane and nuclear pathways. J Pharmacol Exp Ther 307:839-845
67. Xu Y, Traystman RJ, Hurn PD, Wang MM 2003 Neurite-localized estrogen receptor-α mediates rapid signaling by estrogen. J Neurosci Res 74:1-11
68. Marquez DC, Pietras RJ 2001 Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells. Oncogene 20:5420-5430
69. Milanini-Mongiat J, Pouyssegur J, Pages G 2002 Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases: their implication in vascular endothelial growth factor gene transcription. J Biol Chem 277:20631-20639
70. Schafer G, Cramer T, Suske G, Kemmner W, Wiedenmann B, Hocker M 2003 Oxidative stress regulates vascular endothelial growth factor-A gene transcription through Sp1- and Sp3-dependent activation of two proximal GC-rich promoter elements. J Biol Chem 278:8190-8198
71. Clark JD, Mani SK 1994 Actions of ovarian steroid hormones. In: Knobil E, Neill JD, eds. The physiology of reproduction. New York: Raven Press; 1011-1062
72. Kazi AK, Koos RD, Comparison of the effects of estrogen and relaxin on binding of estrogen receptors and coregulators to an estrogen-responsive gene promoter using chromatin immunoprecipitation. Program of the 85th Annual Meeting of The Endocrine Society, Philadelphia, PA, 2003, p 328 (Abstract P2-86)
73. Bermont L, Lamielle F, Lorchel F, Fauconnet S, Esumi H, Weisz A, Adessi GL 2001 Insulin up-regulates vascular endothelial growth factor and stabilizes its messengers in endometrial adenocarcinoma cells. J Clin Endocrinol Metab 86:363-368
74. Ruohola JK, Valve EM, Karkkainen MJ, Joukov V, Alitalo K, Harkonen PL 1999 Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Mol Cell Endocrinol 149:29-40
75. Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL 2001 HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 21:3995-4004
76. Navarro FJ, Mirkin S, Archer DF 2003 Effect of raloxifene, 17β-estradiol, and progesterone on mRNA for vascular endothelial growth factor isoforms 121 and 165 and thrombospondin-1 in Ishikawa cells. Fertil Steril 79:1409-1415
77. Kodama T, Shimizu N, Yoshikawa N, Makino Y, Ouchida R, Okamoto K, Hisada T, Nakamura H, Morimoto C, Tanaka H 2003 Role of the glucocorticoid receptor for regulation of hypoxia-dependent gene expression. J Biol Chem 278:33384-33391
78. Huang LE, Ho V, Arany Z, Krainc D, Galson D, Tendler D, Livingston DM, Bunn HF 1997 Erythropoietin gene regulation depends on heme-dependent oxygen sensing and assembly of interacting transcription factors. Kidney Int 51:548-552
79. Sanchez-Elsner T, Botella LM, Velasco B, Langa C, Bernabeu C 2002 Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-β pathways. J Biol Chem 277:43799-43808
80. Miki N, Ikuta M, Matsui T 2004 Hypoxia-induced activation of the retinoic acid receptor-related orphan receptor α4 gene by an interaction between hypoxia-inducible factor-1 and Sp1. J Biol Chem 279:15025-15031
81. Brunnberg S, Pettersson K, Rydin E, Matthews J, Hanberg A, Pongratz I 2003 The basic helix-loop-helix-PAS protein ARNT functions as a potent coactivator of estrogen receptor-dependent transcription. Proc Natl Acad Sci USA 100:6517-6522
82. Kimura H, Weisz A, Kurashima Y, Hashimoto K, Ogura T, D'Acquisto F, Addeo R, Makuuchi M, Esumi H 2000 Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 95:189-197
83. Michiels C, Minet E, Michel G, Mottet D, Piret JP, Raes M 2001 HIF-1 and AP-1 cooperate to increase gene expression in hypoxia: role of MAP kinases. IUBMB Life 52:49-53
84. Shweiki D, Itin A, Neufeld G, Gitay-Goren H, Keshet E 1993 Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 91:2235-2243
85. Karuri AR, Kumar AM, Mukhopadhyay D 1998 Differential expression and selective localization of vascular permeability factor/vascular endothelial growth factor in the rat uterus during the estrous cycle. J Endocrinol 159:489-499
86. Yi XJ, Jiang HY, Lee KK, O WS, Tang PL, Chow PH 1999 Expression of vascular endothelial growth factor (VEGF) and its receptors during embryonic implantation in the golden hamster (Mesocricetus auratus). Cell Tissue Res 296:339-349
87. Daikoku T, Matsumoto H, Gupta RA, Das SK, Gassmann M, DuBois RN, Dey SK 2003 Expression of hypoxia-inducible factors in the peri-implantation mouse uterus is regulated in a cell-specific and ovarian steroid hormone-dependent manner. Evidence for differential function of HIFs during early pregnancy. J Biol Chem 278:7683-7691
88. Zhang J, Salamonsen LA 2002 Expression of hypoxiainducible factors in human endometrium and suppression of matrix metalloproteinases under hypoxic conditions do not support a major role for hypoxia in regulating tissue breakdown at menstruation. Hum Reprod 17:265-274